Skip to main content
SpringerLink
Log in

Helicobacter pylori and NSAID-induced gastric ulcer in a Japanese population

  • International Forum 1
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

A recent meta-analysis by Huang et al. clarified that Helicobacter pylori infection and nonsteroidal antiinflammatory drugs (NSAIDs) are important factors for peptic ulcer. The results showed that the risk for ulcer in NSAID(+)/H. pylori(+) patients was 61.1 fold higher when compared with NSAID(−)/H. pylori(−) patients. Some gastric ulcers detected in patients on NSAID therapy may actually be caused by H. pylori, but it is difficult to differentiate NSAID-induced gastric ulcer from H. pylori-induced gastric ulcer. Several studies have investigated the effects of H. pylori eradication on ulcer healing. One study reported that H. pylori eradication actually lowered the healing rate of gastric ulcers. Because there have been no studies finding that H. pylori eradication facilitates healing, H. pylori eradication is not recommended for NSAID users. Concerning the efficacy of H. pylori eradication in the prevention of NSAID-induced gastric ulcer, a meta-analysis concluded that among all patients on NSAID therapy, H. pylori eradication lowered the prevalence of ulcer, which was particularly marked in NSAID-naïve patients. When compared with those of proton pump inhibitors (PPIs), the preventative effects of H. pylori eradication were inferior. In Japan, national health insurance does not cover procedures that prevent or lower the risk for NSAID-induced ulcer. When administering NSAID to patients with risk factors, it is desirable to administer antiulcer agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer disease: a meta-analysis. Lancet 2002;359:14–22.

    Article  PubMed  CAS  Google Scholar 

  2. Bianchi-Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in long-term NSAID users. Response to omeprazole dual therapy. Gut 1996;39:22–26.

    Article  PubMed  CAS  Google Scholar 

  3. Chan FK, Sung JJ, Suen R, Lee YT, Wu JC, Leung WK, et al. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther 1998;12:1201–1205.

    Article  PubMed  CAS  Google Scholar 

  4. Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Filipowicz-Sosnowska A, Lanas A, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on nonsteroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1998;352:1016–1021.

    Article  PubMed  CAS  Google Scholar 

  5. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007;42:1–15.

    Article  PubMed  Google Scholar 

  6. Fujioka T, Yoshiiwa A, Okimoto T, Kodama M, Murakami K. Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects. J Gastroenterol 2007;42(suppl 17):3–6.

    Article  PubMed  Google Scholar 

  7. Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S, Yoshida Y, et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol 2006;62:765–772.

    Article  PubMed  CAS  Google Scholar 

  8. Yamao J, Kikuchi E, Matsumoto M, Nakayama M, Ann T, Kojima H, et al. Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE-famotidine or rebamipide in comparison by endoscopy). J Gastroenterol 2006;41(12):1178–1185.

    Article  PubMed  CAS  Google Scholar 

  9. Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM. Superiority of lansoprazole vs. ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. Arch Intern Med 2000;160:1455–1461.

    Article  PubMed  CAS  Google Scholar 

  10. Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking lowdose aspirin or naproxen. N Engl J Med 2001;344:967–973.

    Article  PubMed  CAS  Google Scholar 

  11. Lai KC, Lam SK, Cu KM, Wong BC, Hui WM, Hu WH, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002;346:2033–2038.

    Article  PubMed  CAS  Google Scholar 

  12. Chan FK, Sung JJ, Chung SC, To KF, Yung MY, Leung VK, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997;350(9083):975–979.

    Article  PubMed  CAS  Google Scholar 

  13. Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002;359:9–13.

    Article  PubMed  CAS  Google Scholar 

  14. Labenz J, Blum AL, Bolten WW, Dragosics B, Rosch W, Stolte M, Koelz HR. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. Gut 2002;51:329–335.

    Article  PubMed  CAS  Google Scholar 

  15. Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Filipowicz-Sosnowska A, Lanas A, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on nonsteroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet 1998;352(9133):1016–1021.

    Article  PubMed  CAS  Google Scholar 

  16. Lai KC, Lau CS, Ip WY, Wong BC, Hui WM, Hu WH, et al. Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2003;17:799–805.

    Article  PubMed  CAS  Google Scholar 

  17. Vergara M, Catalan M, Gisbert JP, Calvet X. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005;21:1411–1418.

    Article  PubMed  CAS  Google Scholar 

  18. Guideline for Clinical Practice of Gastric Ulcer Based on EBM. 2nd ed. (in Japanese). Tokyo: Jiho; 2007. p. 101–110.

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Oita, 879-5593, Japan

    Kazunari Murakami, Tadayoshi Okimoto, Masaaki Kodama, Jin Tanahashi, Shigeaki Yasaka, Kunimitsu Inoue, Masahiro Uchida, Juro Anan, Kazuhiro Mizukami, Takashi Abe, Masahide Watada & Toshio Fujioka

Authors
  1. Kazunari Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tadayoshi Okimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaaki Kodama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jin Tanahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shigeaki Yasaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kunimitsu Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masahiro Uchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Juro Anan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kazuhiro Mizukami
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Takashi Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Masahide Watada
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Toshio Fujioka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murakami, K., Okimoto, T., Kodama, M. et al. Helicobacter pylori and NSAID-induced gastric ulcer in a Japanese population. J Gastroenterol 44 (Suppl 19), 40–43 (2009). https://doi.org/10.1007/s00535-008-2259-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-008-2259-5

Key words

Search

Navigation